Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARVN Arvinas Holding Company LLC

盘前交易 05-06 05:47:13 EDT

7.63

-0.09

-1.17%

最高7.91	最低7.33	成交量353.77万
今开7.50	昨收7.72	日振幅7.51%
总市值5.57亿	流通市值4.95亿	总股本7,299万
成交额2,685万	换手率5.46%	流通股本6,484万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARVN","market":"US","secType":"STK","nameCN":"Arvinas Holding Company LLC","latestPrice":7.63,"timestamp":1746475200000,"preClose":7.72,"halted":0,"volume":3537726,"delay":0,"floatShares":64842558,"shares":72991390,"eps":-0.646324,"marketStatus":"盘前交易","change":-0.09,"latestTime":"05-06 05:47:13 EDT","open":7.502,"high":7.91,"low":7.33,"amount":26846128.208284,"amplitude":0.07513,"askPrice":8.3,"askSize":100,"bidPrice":7.1,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.646324,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746538200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1538020800000,"exchange":"NASDAQ","adjPreClose":7.63,"postHourTrading":{"tag":"盘后","latestPrice":7.6784,"preClose":7.63,"latestTime":"19:53 EDT","volume":113842,"amount":868583.5002,"timestamp":1746489202609},"volumeRatio":0.5911374448784797,"optionData":{"bulkOrders":[{"symbol":"ARVN","call":true,"expireDate":1750392000000,"strike":"7.5","timestamp":1746457409941,"price":1.21,"volume":1200,"amount":145200,"type":"-"}]},"impliedVol":0.927,"impliedVolPercentile":0.6707},"requestUrl":"/m/hq/s/ARVN/wiki","defaultTab":"wiki","newsList":[{"id":"2533156913","title":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由10.00美元调整至9.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533156913","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533156913?lang=zh_cn&edition=full","pubTime":"2025-05-06 05:25","pubTimestamp":1746480350,"startTime":"0","endTime":"0","summary":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由10.00美元调整至9.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/06052550140586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2533530323","title":"Truist Securities：下调Arvinas(ARVN.US)评级，由买入调整至持有评级, 目标价由21.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533530323","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533530323?lang=zh_cn&edition=full","pubTime":"2025-05-06 00:15","pubTimestamp":1746461727,"startTime":"0","endTime":"0","summary":"Truist Securities：下调Arvinas(ARVN.US)评级，由买入调整至持有评级, 目标价由21.00美元调整至11.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/06001550140123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"1122968446","title":"异动解读 | Arvinas股价盘中大跌5%，加拿大蒙特利尔银行大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1122968446","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122968446?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:00","pubTimestamp":1746453633,"startTime":"0","endTime":"0","summary":"生物制药公司Arvinas Holding Company LLC（股票代码：ARVN）今日盘中股价大跌5.05%，引起市场广泛关注。\n\n这一显著跌幅很可能与加拿大蒙特利尔银行（BMO）最新发布的研究报告有关。BMO虽然维持了Arvinas的\"优于大市\"评级，但大幅下调了其目标价，从此前的20美元降至10美元，降幅高达50%。\n\n如此大幅度的目标价下调无疑打击了投资者信心。尽管BMO仍然看好Arvinas的长期发展前景，但目标价的大幅下调可能反映出分析师对公司短期内面临的挑战持谨慎态度。投资者可能需要密切关注Arvinas未来的业务发展和财务表现，以评估公司的长期投资价值。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Arvinas股价盘中大跌5%，加拿大蒙特利尔银行大幅下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":0},{"id":"2533628582","title":"加拿大蒙特利尔银行：维持Arvinas(ARVN.US)评级，由优于大市调整至优于大市评级, 目标价由20.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533628582","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533628582?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:13","pubTimestamp":1746450821,"startTime":"0","endTime":"0","summary":"加拿大蒙特利尔银行：维持Arvinas(ARVN.US)评级，由优于大市调整至优于大市评级, 目标价由20.00美元调整至10.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/05211350139484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN","BMO"],"gpt_icon":0},{"id":"1117199844","title":"异动解读 | 多家分析师大幅下调目标价，Arvinas股价反而盘中大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117199844","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117199844?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:43","pubTimestamp":1746207830,"startTime":"0","endTime":"0","summary":"生物制药公司Arvinas周五盘中股价大涨5.12%，引发市场关注。这一涨势出现在多家华尔街分析师大幅下调该公司目标股价之际，形成鲜明对比。这些分析师行动通常会对股价产生负面影响，但Arvinas股价却出现逆势上涨。分析人士认为，在如此多的下调评级后，Arvinas股价不跌反涨，可能反映出市场对该公司基本面的某些积极看法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":0},{"id":"2532263822","title":"高盛：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由12.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532263822","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532263822?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:52","pubTimestamp":1746204723,"startTime":"0","endTime":"0","summary":"高盛：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由12.00美元调整至8.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03005250110076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2532604824","title":"Guggenheim：维持Arvinas(ARVN.US)评级，由买入调整至买入评级, 目标价由32.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532604824","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532604824?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:11","pubTimestamp":1746202319,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Arvinas(ARVN.US)评级，由买入调整至买入评级, 目标价由32.00美元调整至16.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03001150109992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"1193052835","title":"异动解读 | Arvinas股价盘中大跌5.12%，多家券商大幅下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1193052835","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193052835?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:59","pubTimestamp":1746197957,"startTime":"0","endTime":"0","summary":"周五盘中，生物技术公司Arvinas股价大跌5.12%，引发市场关注。消息面上，多家知名券商大幅下调了Arvinas的目标股价。其中，杰富瑞将Arvinas的评级从\"买入\"下调至\"持有\"，目标价从52美元大幅下调至10美元。分析人士认为，如此多的机构大幅下调Arvinas的目标价，暗示该公司可能面临重大不利因素或业务前景恶化。市场将密切关注Arvinas未来的业务进展和财报表现，以评估公司的长期发展前景。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Arvinas股价盘中大跌5.12%，多家券商大幅下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":0},{"id":"2532483948","title":"杰富瑞投资银行：下调Arvinas(ARVN.US)评级，由买入调整至持有评级, 目标价由52.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532483948","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532483948?lang=zh_cn&edition=full","pubTime":"2025-05-02 19:47","pubTimestamp":1746186458,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：下调Arvinas(ARVN.US)评级，由买入调整至持有评级, 目标价由52.00美元调整至10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02194750105816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"1123651810","title":"异动解读 | Arvinas股价盘前暴跌37.72%，尽管季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123651810","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123651810?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:51","pubTimestamp":1746107509,"startTime":"0","endTime":"0","summary":"生物技术公司Arvinas Holding Company LLC今日盘前股价大幅下跌37.72%，尽管公司刚刚公布的季度业绩远超分析师预期。这一反常现象引发了市场的广泛关注和讨论。根据Arvinas最新发布的财报，截至3月31日的季度调整后每股收益为1.14美元，远高于分析师平均预期的每股亏损0.95美元。然而，尽管财报数据表现强劲，Arvinas股价却出现大幅下跌，这种反常现象令市场参与者感到困惑。此外，考虑到Arvinas股价在本季度上涨了37.0%，今日的大跌也可能是投资者获利回吐的结果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Arvinas股价盘前暴跌37.72%，尽管季度业绩超预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":1},{"id":"2532008157","title":"Arvinas, Inc.股价重挫33.47% 市值涨1766.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008157?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:30","pubTimestamp":1746106211,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时30分，Arvinas, Inc.股票出现波动，股价大幅下跌33.47%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213011aa2c8037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213011aa2c8037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2528721132","title":"高盛：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由15.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528721132","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528721132?lang=zh_cn&edition=full","pubTime":"2025-04-18 01:31","pubTimestamp":1744911106,"startTime":"0","endTime":"0","summary":"高盛：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由15.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18013149639969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2528419977","title":"Arvinas, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528419977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528419977?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:59","pubTimestamp":1744898375,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时59分，Arvinas, Inc.股票出现异动，股价急速拉升5.03%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215936a6be116f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215936a6be116f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2527511110","title":"Arvinas, Inc.盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527511110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527511110?lang=zh_cn&edition=full","pubTime":"2025-04-15 02:50","pubTimestamp":1744656605,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日02时50分，Arvinas, Inc.股票出现波动，股价快速上涨5.04%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为2.63%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415025005aa2c6f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415025005aa2c6f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2526261525","title":"Arvinas, Inc.盘中异动 下午盘股价大涨5.14%报6.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526261525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526261525?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:03","pubTimestamp":1744391021,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时03分，Arvinas, Inc.股票出现波动，股价快速拉升5.14%。截至发稿，该股报6.96美元/股，成交量141.226万股，换手率2.05%，振幅6.80%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.64%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。该信息摘要如下：Truist Securities：维持Arvinas评级，由买入调整至买入评级, 目标价由65.00美元调整至21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412010341aa2c6d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412010341aa2c6d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2518745334","title":"辉瑞乳腺癌新药Vepdegestrant研究喜忧参半，授权方Arvinas股价暴跌40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745334","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518745334?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:59","pubTimestamp":1741697953,"startTime":"0","endTime":"0","summary":"辉瑞公司的下一代乳腺癌治疗药物 vepdegestrant 在最后阶段的研究中取得了好坏参半的结果，未能延缓所有患者的癌症进展，但达到了针对具有特定基因突变的亚组患者的目标。","market":"hk","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260559.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0306806265.USD","ARVN","SG9999002232.USD","BK4592","BK4534","LU0985481810.HKD","LU1883839398.USD","LU1057294990.SGD","BK4581","LU1023059063.AUD","LU0456855351.SGD","SGXZ57979304.SGD","BK4585","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0170899867.USD","LU1894683264.USD","SG9999001176.SGD","BK4533","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","BK4599","SG9999001176.USD","SG9999002224.SGD","LU0122379950.USD","BK4007","LU0225771236.USD","LU0321505868.SGD","LU1066051498.USD","LU0225284248.USD","SG9999013999.USD","BK4568","LU1066053197.SGD","PFE","LU0868494617.USD","LU0234572021.USD","BK4588","SG9999003800.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4550","LU0306807586.USD","IE000M9KFDE8.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2518495206","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518495206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518495206?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:13","pubTimestamp":1741630432,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时13分，Arvinas, Inc.股票出现异动，股价急速下挫5.14%。截至发稿，该股报17.34美元/股，成交量57.7109万股，换手率0.84%，振幅6.04%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2517693254","title":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517693254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517693254?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:50","pubTimestamp":1741384237,"startTime":"0","endTime":"0","summary":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08055048605286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2517194729","title":"Arvinas, Inc.盘中异动 下午盘急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194729?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:38","pubTimestamp":1741289911,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时38分，Arvinas, Inc.股票出现异动，股价急速拉升5.20%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2517493229","title":"Arvinas, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517493229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517493229?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:48","pubTimestamp":1741189728,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时48分，Arvinas, Inc.股票出现异动，股价快速上涨5.12%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arvinas.com","stockEarnings":[{"period":"1week","weight":-0.1716},{"period":"1month","weight":0.1631},{"period":"3month","weight":-0.5773},{"period":"6month","weight":-0.7274},{"period":"1year","weight":-0.7675},{"period":"ytd","weight":-0.602}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arvinas, Inc.于2013年2月根据特拉华州法律成立。该公司是一家生物制药公司，致力于通过发现、开发和商业化治疗降低致病蛋白质来改善患有衰弱和危及生命的疾病的患者的生活。该公司使用他们的专有技术平台来设计针对嵌合体或PROTAC的蛋白水解，这些嵌合体旨在利用人体自身的天然蛋白质处理系统来选择性地和有效地降解和去除致病蛋白质。Arvinas Holding Company，LLC相信他们的靶向蛋白质降解方法是一种新的治疗方式，可能提供优于现有方式的独特优势，包括传统的小分子疗法和基于基因的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.025374},{"month":2,"riseRate":0.571429,"avgChangeRate":0.011057},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.187738},{"month":4,"riseRate":0.571429,"avgChangeRate":0.096543},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.125887},{"month":6,"riseRate":0.833333,"avgChangeRate":0.011275},{"month":7,"riseRate":0.666667,"avgChangeRate":0.126111},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.076544},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.103315},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.018156},{"month":11,"riseRate":0.714286,"avgChangeRate":0.161248},{"month":12,"riseRate":0.571429,"avgChangeRate":0.407187}],"exchange":"NASDAQ","name":"Arvinas Holding Company LLC","nameEN":"Arvinas Holding Company LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arvinas Holding Company LLC,ARVN,Arvinas Holding Company LLC股票,Arvinas Holding Company LLC股票老虎,Arvinas Holding Company LLC股票老虎国际,Arvinas Holding Company LLC行情,Arvinas Holding Company LLC股票行情,Arvinas Holding Company LLC股价,Arvinas Holding Company LLC股市,Arvinas Holding Company LLC股票价格,Arvinas Holding Company LLC股票交易,Arvinas Holding Company LLC股票购买,Arvinas Holding Company LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}